Header Logo

Connection

Kelly Standifer to Naltrexone

Back to Details
This is a "connection" page, showing publications Kelly Standifer has written about Naltrexone.
Kelly Standifer
Connection Strength
0.201
Naltrexone
  1. beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells. Eur J Pharmacol. 2000 Aug 18; 402(1-2):R1-37.
    View in: PubMed
    Score: 0.178
  2. Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions. Brain Res. 1990 Dec 03; 535(1):101-9.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.